Inhibitory Effects of Omega-3 Fatty Acids-Based Fish Oil on Cholangiocarcinoma
ISEF · 2016 Third Award
Overview
Intrahepatic cholangiocarcinoma (ICC) is a type of primary liver tumor that is difficult to diagnose, and surgical resection is the only viable therapeutic option for patients. Studies show that long-chain unsaturated omega-3 fatty acids can lower inflammation and cancer cell proliferation. However, the effects of omega-3 fatty acids on cholangiocarcinoma are currently unknown. We utilized human bile duct cancer cells HuCCT1 to explore how omega-3 based fish oil from sources such as dietary supplements affects ICC. The results show that fish oil suppresses inflammation-, cell cycle-, and metastasis-related gene expression. We also established a line of triple-transgenic zebrafish, expressing Hepatitis B Virus X protein (HBx), Hepatitis C Virus Core protein (HCP) and delta-6-desaturase (D6D) genes. HBx+HCP induces ICC and D6D increases the level of omega-3 in the body to suppress tumor progression.
Awards (1)
- Third Award of $1,000 $1,000
Competition history
- ISEF 2016
Resources
Related projects
ISEF · 2019
Inhibition of UCP2 Suppresses Cell Proliferation and Migration of Cholangiocarcinoma through the Regulation of Epithelial-Mesenchymal Transition
ISEF · 2023
Determining Fat Preference for Triple Negative Breast Cancer Cells
ISEF · 2023
Novel Therapeutic Efficacy of Curcumin and Fish Oil (Omega-3 Fatty Acids) on Inhibiting Neuroinflammation and Neuronal Apoptosis in Mus musculus Microglial Cells
ISEF · 2023
Identification and Analysis of Metabolic Inhibitors in Ctnnb1-Driven Hepatocellular Carcinoma (HCC)
Closest projects by meaning, across every fair and year in the corpus.
Source: Regeneron International Science and Engineering Fair